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Abstract 
Introduction: Recent studies suggest the administration of 100% oxygen to hyperoxic levels 
following return-of-spontaneous-circulation (ROSC) post-cardiac arrest may be harmful. 
However, the feasibility and safety of oxygen titration in the prehospital setting is unknown. 
We conducted a multi-centre, phase-2 study testing whether prehospital titration of oxygen 
results in an equivalent number of patients arriving at hospital with oxygen saturations 
SpO2≥94%. 
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Methods: We enrolled unconscious adults with: sustained ROSC; initial shockable rhythm; an 
advanced airway; and an SpO2≥95%. Initially (Sept 2015–March 2016) patients were 
randomised 1:1 to either 2 litres/minute (L/min) oxygen (titrated) or >10L/min oxygen 
(control) via a bag-valve reservoir. However, one site experienced a high number of 
desaturations (SpO2<94%) in the titrated arm and this arm was changed (April 2016) to an 
initial reduction of oxygen to 4L/min then, if tolerated, to 2L/min, and the desaturation limit 
was decreased to <90%.  
Results:  We randomised 61 patients to titrated (n=37: 2L/min=20 and 2-4L/min=17) oxygen 
or control (n=24). Patients allocated to titrated oxygen were more likely to desaturate 
compared to controls ((SpO2<94%: 43% vs. 4%, p=0.001; SpO2<90%: 19% vs. 4%, p=0.09). The 
majority of desaturations (81%) occurred at 2L/min. On arrival at hospital the majority of 
patients had a SpO2 ≥94% (titrated: 90% vs. control: 100%) and all patients had a SpO2 ≥90%. 
One patient (control) re-arrested. Survival to hospital discharge was similar. 
Conclusion: Oxygen titration post-ROSC is feasible in the prehospital environment, but 
incremental titration commencing at 4L/min oxygen flow may be needed to maintain an 
oxygen saturation >90% (NCT02499042).  
 
Key words: oxygen, hyperoxia, out-of-hospital cardiac arrest, heart arrest, post-resuscitation 
care.  
Word count: 2940 
 
 
AC
CE
PT
ED
 M
AN
US
CR
IPT
3 
 
Introduction 
A recent review by the International Liaison Committee in Resuscitation (ILCOR) found that 
the evidence surrounding the optimal delivery of oxygen after successful resuscitation from 
cardiac arrest is of very low quality.(1) Currently, out-of-hospital cardiac arrest (OHCA) 
patients who achieve return of spontaneous circulation (ROSC) receive 100% oxygen during 
transport to hospital and during the initial period in the emergency department (ED). The 
administration of 100% oxygen for the first hours post-ROSC is largely based on the perceived 
benefit of high oxygen levels and not on supportive clinical data. Historically, it has been 
thought that maximizing oxygen delivery during this period is beneficial in a cardiac arrest 
patient who has suffered profound tissue hypoxia. There is also a perceived risk that the early 
lowering of inspired oxygen might result in episodes of hypoxia.  
However, recent data suggest the administration of 100% oxygen to hyperoxic levels (partial 
pressure oxygen [PaO2] >300mmHg) may be harmful. Hyperoxia is seen on the first arterial 
blood gas in approximately 20% of OHCA patients(2, 3), and is experienced by 38% in the first 
six hours of hospitalisation.(4) Systematic reviews of experimental data(5) and a meta-
analysis of human observational studies(6) indicate that hyperoxia during the early post-ROSC 
period may lead to additional neurological injury, and thus result in worse clinical outcomes. 
These findings are biologically plausible given that the administration of additional oxygen 
increases the production of oxygen free-radicals which are known to injure neurones.(7) 
However, it remains unknown from these observational studies whether the hyperoxia is 
simply an association with illness severity rather than a contributor to poor outcome.(8) A 
recent prospective observational study suggests hyperoxia is independent of illness severity 
as a predictor or mortality, but there are currently no large randomised controlled trials in 
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this area.(9)  Clinical trials testing different oxygen targets in the post cardiac arrest period 
has been described as a priority area for research in this setting.(10)  
Given the potential harm of hyperoxia and the paucity of clinical experience with titration of 
oxygen in the prehospital setting, we aimed to conduct a pilot study to determine the 
feasibility of paramedic titration of oxygen delivery in adult patients who have been 
resuscitated after OHCA. Specifically, we tested the hypothesis that prehospital oxygen 
titration would not reduce the proportion of patients who arrived at the emergency 
department (ED) with a SpO2 greater than or equal to 94%.   
Methods 
Trial design 
We conducted a phase 2, multi-centre, parallel, single-blinded, randomised (1:1) controlled 
trial in the Australian cities of Melbourne and Adelaide. The study was approved by the 
Monash University Human Ethics Committee (CF14/2953 – 2014001634) and the Royal 
Adelaide Hospital Ethics Committee (141011).  The trial was registered on ClinicalTrials.gov 
(NCT02499042).  
Initially, patients were randomly assigned to either 2 litres/minute (L/min) oxygen (titrated) 
or >10 L/min oxygen (control) with the oxygen administered via a bag-valve reservoir (BVR), 
otherwise known as a self-inflating bag. However, following a high number of desaturations 
(SpO2<94% in 8/20 patients) at the main recruiting site, the titrated arm was changed at this 
site (April 2016) to an initial reduction of oxygen to 4 L/min, and then if tolerated, to 2 L/min. 
The study was terminated early (n=61) due to the introduction of mechanical ventilators at 
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the main recruiting site, and the inability to replicate the equivalent FiO2 of the protocol using 
these ventilators.  
Participants 
Eligible participants were: adults (age≥18 years), unconscious (Glasgow Coma Scale <9) with 
an advanced airway (endotracheal tube [ETT] or supraglottic airways [SGA]) in situ and 
sustained ROSC following an OHCA of presumed cardiac cause, and an initial monitored 
rhythm assessed as shockable (ventricular fibrillation or pulseless ventricular tachycardia). 
Exclusion criteria were: paramedic witnessed OHCAs, Sp02 <95% or no pulse oximetry trace, 
known or suspected to be pregnant; dependant on others for activities of daily living (i.e. 
facilitated care or nursing home residents); and evidence of a “Not for Resuscitation” order.  
Setting 
The study took place in two Australian cities between July 2015 and May 2017. Melbourne, 
the capital city of the state of Victoria with a population over 4.5 million, is serviced by 
Ambulance Victoria. The second city, Adelaide, is the capital city of South Australia (SA) and 
has a population of almost 1.2 million with emergency ambulance services provided by the 
SA Ambulance Service. 
The ambulance services are detailed elsewhere(11), however there were differences between 
the two ambulance services in airway management at the time of this study.  At Ambulance 
Victoria, SGAs are used during the arrest and are replaced by endotracheal tubes (ETT) either 
during CPR or soon after ROSC is achieved. If airway reflexes are present, intubation is 
facilitated using fentanyl and suxamethonium. Sedation is maintained after intubation with a 
midazolam and opiate infusion. In the SA Ambulance Service, no muscle relaxants are used, 
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and an ETT or SGA is inserted either during CPR or immediately post–ROSC. Sedation using 
midazolam may be used to maintain the airway. 
Intervention 
Intra-arrest oxygen delivery and ambulance cardiac arrest care was unchanged over the study 
period, and followed the Australian and New Zealand Committee on Resuscitation (ANZCOR) 
Guidelines. All prehospital oxygen was delivered by hand ventilation using a BVR.  
Following ROSC, oxygen was delivered at a flow rate of ≥10 L/min via BVR connected to the 
airway until a satisfactory pulse oximeter trace and reading was achieved. If eligibility criteria 
were met, the paramedics randomised the patients by the opening of an opaque envelope 
containing a computer-generated allocation to either the control or titrated group.   
Patients in the control group continued to receive oxygen at ≥10 L/min. Patients in the titrated 
group had oxygen reduced to either 2 or 4 L/min. Oxygen saturations were continuously 
measured by pulse oximetry via a finger probe. Oxygen flow into the BVR in the titrated group 
was to be immediately increased to ≥10 L/min if the patient rearrested, if their pulse oximeter 
trace failed despite adequate probe placement, or if they desaturated (Sp02 <94% on initial 
protocol and Sp02 <90% on amended protocol in Victoria).   
If a patient’s advanced airway was removed post-randomisation because of improving 
conscious state, then standard care was used (i.e. face mask with oxygen ≥10 L/min). For 
patients who were to be intubated post-ROSC, ventilation with high-flow oxygen continued 
during the intubation process and randomisation was delayed until two minutes after the ETT 
was confirmed as correctly placed and the SpO2 was ≥95%. 
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The intervention ceased at ED handover, at which time the patient received oxygen therapy 
as determined by the treating emergency medicine physician. 
Outcomes 
The primary outcome was a SpO2 ≥94% on arrival at hospital. Secondary outcomes were a 
SpO2 ≥90% on arrival at hospital, re-arrest during ambulance transport and survival at 
hospital discharge.   
Data Collection 
Study data were collected from the ambulance patient care record (PCR) by trained trial staff. 
Hospital survival was collected by the Victorian Ambulance Cardiac Arrest Registry 
(VACAR)(12) and the SA Ambulance Service Cardiac Arrest Registry.(13) Data collected 
included demographics, arrest characteristics (using Utstein definitions)(14), randomisation 
allocation, vital signs at randomisation and hospital arrival, airway type, medications, 
desaturations , changes in oxygen flow, and re-arrests during pre-hospital care. No hospital 
data was collected other than hospital discharge survival. Final Sp02 on arrival at hospital was 
recorded by paramedics and extracted from the PCR.  
Sample size and analysis 
The intended sample size was determined from existing data from the VACAR. For January to 
June 2014, there were 102 patients who met the inclusion criteria and had an oxygen 
saturation recorded by paramedics on arrival to the ED. All these patients received 100% 
oxygen (oxygen flow at 10L/min into the BVM). Pulse oximetry data at ED arrival on 100% 
oxygen were: SpO2 <94% in 31%, SpO2 =94-96% in 14% and SpO2 >96% in 55% of cases. It 
was anticipated that a titration of oxygen strategy to a target oxygen saturation of 94-96% 
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would be achieved in 33% of titrated oxygen patients compared to 14% in the 100% oxygen 
group. A sample of 88 patients in each arm (n=176) would be needed to achieve 80% power 
(alpha 0.05).   
Descriptive data are presented as mean (standard deviations [SD]) or median (interquartile 
range [IQR]). Mann-Whitney and Student T-tests were used to compare continuous data and 
Fisher’s Exact test for categorical data. A p-value <0.05 was considered statistically significant. 
All analyses were performed in STATA (Version15).   
Ethics 
The study was granted a waiver of consent by the two approving Ethics Committees. At both 
sites, survivors were notified of enrolment approximately two months after hospital 
discharge and were given contact details for further information and the option to opt out of 
data collection.  
Results 
We randomised 62 patients to titrated (n=37) or control (n=25) groups (Figure 1). No patients 
were lost in follow-up and one patient requested data withdrawal (control arm). The 
demographics, arrest and clinical characteristics between the groups of the remaining 61 
patients were similar (Table 1).  
The majority of patients had an SGA inserted initially (95%), and were intubated post-ROSC. 
Use of sedation and paralysis were similar between groups (Table 2), however slightly more 
patients in the control group received post-ROSC adrenaline (67% vs 49%).  
On average the titration of oxygen commenced 35 minutes after ROSC (Table 2). Overall, 
oxygen delivery in the titrated group was increased per protocol due to desaturations in 16 
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(43%) patients. All patients who desaturated responded to the increase in oxygen (≥10L/min), 
with 100% arriving at ED with SpO2 >90%. The majority of desaturations (81%) occurred 
following the titration to 2L/min . Table 3 compares the characteristics and outcomes by 
desaturation (<94% and <90%) in the titrated oxygen group. Although the numbers were 
small for statistical comparisons, patients who desaturated were less likely to have factors 
associated with improved outcomes (e.g. shorter downtimes and witnessed arrests). These 
patients were also more likely to have been intubated intra-arrest and to have received 
sedation, particularly morphine and midazolam.   
On arrival at hospital the majority of patients had a SpO2 ≥94%: 33/37 (90%) titrated and 
24/24 (100%) control (Table 4).  There was reasonable separation in mean oxygen saturation 
on arrival at ED between the groups (titrated: 97% vs. control: 99%, p=0.004). One patient in 
the control group re-arrested. Survival to hospital discharge was similar between the groups 
(titrated: 51% vs. control: 54%), and when examined by desaturation status in the titrated 
group (desaturated <94%: 56% vs. no desaturation: 48%, p=0.74).  
Discussion 
We found that the titration of oxygen post-ROSC is feasible in the prehospital environment 
using a simple decrease in the oxygen flow into a bag/valve device with oxygen reservoir. We 
observed no significant adverse events, and desaturations were brief and correctable. There 
were no re-arrests in the titrated arm and no difference between the groups in hospital 
survival. While we observed brief desaturations in 43% of titrated cases, the majority (81%) 
of these occurred following titration to low-flow oxygen (2L/min).  
There have been two previous pilot trials comparing early oxygen titration with 100% oxygen 
in patients resuscitated from OHCA.(15, 16) In a Finnish study, patients were randomised to 
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be ventilated either with a fraction of inspired oxygen (FiO2) of 0.3 or 1.0 for the first 60 
minutes post-ROSC.(15) This study concluded that most patients had acceptable oxygenation 
when ventilated with 30% oxygen during the immediate post-ROSC period. In a New Zealand 
study, 18 post-ROSC patients were randomised to receive either titrated oxygen (targeting 
90-94%) or 100% oxygen commencing in the pre-hospital setting via a BMR.(16) This study 
was stopped early due to high numbers of desaturations in the titrated arm. However, the 
accuracy of the readings of the pulse oximeter in this study was uncertain as all readings were 
downloaded from the monitoring device and not just those readings confirmed by paramedics 
as having an adequate trace. Thus, many readings may have been included where the 
recorded oxygen saturation was inaccurate.   
In the titrated arm of our original protocol, oxygen was titrated to 2 L/min and delivered by a 
BVR device. This level was based on bench tests which found that 2 L/min via a BVR provides 
oxygen at an FiO2 of approximately 50% when delivered at a rate of 14/min and a tidal volume 
of 600mL.(17) However, our results showed that titration of oxygen to 2L/min in practice 
resulted in a significant number of patients desaturating below the initially acceptable oxygen 
saturation level of 94%. Hence, we then performed incremental titration at our major 
recruiting site, first to 4 L/min then if tolerated to 2 L/min.  
The lowest safe oxygen saturation target following resuscitation from cardiac arrest is 
uncertain. Recently, the Australian and New Zealand Thoracic Society changed the normal 
low oxygen target from 94% to 92%.(18) Other researchers in this area have also used a lower 
target. For example, Eastwood et al. ICU study had safely targeted a SpO2 of 88-92%.(19)  
Based on these changes, we lowered the desaturation limit to <90% in the second period of 
this trial.   
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The desaturations (<94%) following the immediate titration to low flow oxygen seen in both 
this and the Young et al.(16) trial are most likely related to difficulties maintaining BVR 
inflations at the correct tidal volume and rate with manual ventilation in the prehospital 
environment. A laboratory investigation found FiO2 levels at low flow oxygen (0.5-6 L/min) is 
highly dependant on tidal volumes and inflation rates.(17) For example, at 2 L/min, FiO2 
varied between 0.27 and 0.62 ─with lower oxygen concentrations seen with higher tidal 
volumes or faster inflation rates. In the prehospital environment, it may be difficult to 
maintain a consistent ventilation while multitasking and extricating the patient from the 
scene. This variation may be an issue in future research if unmeasured, but may be corrected 
with careful monitoring, paramedic education and practice(20) or the use of prehospital 
mechanical ventilators with standard settings.  
Although we examine factors related to desaturation, these results must be interpreted with 
caution due to the sample size. Not surprisingly the patients who desaturated in the titrated 
group were more likely to have the factors that may require careful and possibly slower 
oxygen titration (e.g. older age, longer downtimes, and sedation). Intra-arrest intubation was 
rare in our study, as it is only used with difficult airways (e.g. copious vomitus or supra-glottic 
airway failure), but was seen in a high proportion of patients who desaturated. We 
recommend caution in these patients.  Importantly, desaturations were not associated with 
lower survival. Unfortunately, we were only able to collect hospital survival in this pilot study, 
so are unable to provide comment of the impact of prehospital oxygen titration on other 
outcomes, such as neurological status.    
Our results are subject to a number of potential limitations. First, we did not achieve our 
sample size. The main recruiting site introduced mechanical ventilators during the study and 
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we were unable to include ventilated patients due to differences in achievable FiO2 levels. 
Second, we were unable to blind paramedics or data collectors to allocation. Third, due to 
limited funding and the ongoing establishment of the cardiac arrest registry in South Australia 
we were unable to track reasons why patients were not enrolled in the study. Fourth, while 
there were no major prehospital adverse events associated with oxygen titration in our study, 
we did not collect hospital data and so were unable to measure oxygenation using an arterial 
blood gas analysis or subsequent adverse events. However, such data may be affected by 
hypoxic events after hospital arrival; which are seen in as many 78% of cases in the first 24-
hours.(8) Despite episodes of brief desaturations, all patients in our study had acceptable 
oxygen saturation levels (>90%) on arrival at hospital and similar survival between groups and 
in those who desaturated. We did not collect data related to neurological outcome.  
Following this pilot study and the growing body of evidence suggesting harm from 
hyperoxia,(4) we have commenced a Phase 3 randomised control trial (NCT3138005), 
comparing titration of oxygen to maintain oxygen saturations at either 90-94% or 98-100%. 
This study will include three Australian cities (Greater Melbourne, Adelaide and Perth) and 
intends to enrol 1416 OHCA patients. The main study intervention will continue in-hospital 
and conclude following the first arterial blood gas in the intensive care unit. The primary 
outcome of the trial will be survival to hospital discharge and numerous secondary outcomes 
such as: neurological outcome; hypoxic episodes; recurrent cardiac arrest; ICU survival; length 
of stay; and quality of life and survival at 12-months. The limitations of this pilot study will be 
addressed in the main study which will include: inclusion of patients on prehospital ventilators 
and OHCA of all cardiac rhythms; tracking patients not enrolled; a lower level of acceptable 
oxygen after titration (O2sat <90%); collection of inhospital data and a wider range of 
outcome data.   
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In summary, our pilot study found that oxygen titration is feasible in the prehospital 
environment, but does require incremental titration and careful pulse oximeter monitoring.  
An increase in oxygen delivery may be required in some patients to avoid hypoxia. 
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Figure Legend 
Figure 1. Diagram of study intervention.  
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Table 1. Comparison of patient characteristics by study group.  
N (%) 2-4L/MIN 
(N=37) 
≥10L/MIN 
(N=24) 
Age, mean (SD) 64 (13.5) 60.5 (9) 
Male 32 (86) 17 (75) 
Witnessed arrest 27 (73) 18 (75) 
Bystander cardiopulmonary resuscitation 31 (84) 23 (96) 
Downtime, median (IQR) 18.5 (16-27) 19.5 (16-29) 
Supraglottic airway 34 (95) 23 (96) 
Supraglottic airway only 
Endotracheal tube intra-arrest 
Endotracheal tube post-ROSC 
Rapid sequence intubation post-ROSC 
2 (5) 
5 (14) 
18 (49) 
12 (32) 
1 (4) 
7 (29) 
9 (38) 
7 (29) 
Midazolam 
Morphine 
Fentanyl 
Pancuronium 
PostROSC adrenaline 
29 (78) 
25 (68) 
14 (38) 
10 (27) 
18 (49) 
20 (83) 
14 (58) 
9 (38) 
7 (29) 
16 (67) 
ROSC: return of spontaneous circulation 
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Table 2: Comparison of oxygenation by study group 
N (%) 2-4L/MIN 
(N=37) 
≥10L/MIN 
(N=24) 
P-value 
SpO2 at randomisation, mean 
(SD) 
98 (2) - - 
Time from ROSC to 
randomisation (minutes) , mean 
(SD) 
35 (17) - - 
Time from randomisation to ED 
(minutes), mean (SD) 
50 (13) - - 
Oxygen flow level at ED 
 2L/min 
4L/min 
10L/min 
 
20 (54) 
1 (3) 
16 (43) 
 
0 (0) 
0 (0) 
24 (100) 
 
<0.001 
Lowest SpO2, mean (SD) 94 (4) 98 (3) <0.001 
Desaturation  
<94% 
<90%      
 
16 (43) 
7 (19) 
 
1 (4) 
1 (4) 
 
0.001 
0.13 
SpO2 at ED, mean (SD)* 97 (3) 99 (2) 0.004 
*p=0.004 
SpO2: oxygen saturation; ROSC: return of spontaneous circulation; ED: emergency 
department 
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Table 3. Characteristics and outcomes of those who desaturated (<94% and <90%) in titrated group (n=37).  
N (%) Desaturated <94% Desaturated <90% 
 No (n=21) Yes (n=16) p-value No (n=30) Yes (n=7) p-value 
Age, mean (SD) 64 (12) 65 (16) 0.88 62.5 (12) 74 (16) 0.04 
Male  18 (86) 14 (88) 0.99 25 (83) 7 (100) 0.56 
Witnessed 16 (76) 11 (69) 0.72 23 (77) 4 (57) 0.36 
Bystander cardiopulmonary 
resuscitation  
19 (90) 12 (75) 0.21 26 (87) 5 (71) 0.32 
Downtime, median (IQR)  17 (15.5-26) 21.5 (15.5-28) 0.37 18 (15-26) 27 (19-35) 0.04 
Supraglottic airway 19 (90) 16 (100) 0.49 28 (93) 7 (100) 0.99 
Supraglottic airway only 
Endotracheal tube intra-arrest 
Endotracheal tube post-ROSC 
Rapid sequence intubation post-ROSC 
2 (10) 
1 (5) 
12 (57) 
6 (29) 
0 (0) 
4 (25) 
6 (37.5) 
6 (37.5) 
0.20 
0.07 
0.24 
0.57 
2 (7) 
2 (7) 
15 (50) 
11 (37) 
0 (0) 
3 (43) 
3 (43) 
1 (14) 
0.99 
0.04 
0.99 
0.39 
Midazolam 15 (71) 14 (87) 0.42 22 (73) 7 (100) 0.31 
Morphine 11 (52) 14 (87.5) 0.04 18 (60) 7 (100) 0.07 
Fentanyl 8 (38) 6 (37.5) 0.99 13 (43) 1 (14) 0.22 
Pancuronium 4 (19) 6 (37.5) 0.27 8 (27) 2 (29) 0.99 
PostROSC adrenaline 9 (43) 9 (56) 0.52 13 (43) 5 (71) 0.18 
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Survived to hospital discharge 10 (48) 9 (56) 0.60 16 (53) 3 (43) 0.69 
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Table 4. Comparison of outcomes by study group 
N (%) 
 
2-4L/MIN 
(N=37) 
≥10L/MIN 
(N=24) 
SpO2 at ED ≥94% 33 (90) 24 (100) 
SpO2 at ED ≥90% 37 (100) 25 (100) 
Re-arrest prehospital 0 (0) 1 (4) 
Survived to hospital 
discharge 
19 (51) 13 (54) 
SpO2: oxygen saturation; ED: emergency department 
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